Transdermal delivery composite using covalent organic framework and polymer
The present invention relates to a transdermal delivery composite comprising a cyclodextrin-based covalent organic framework and polymer. In addition, the present invention relates to a cosmetic composition comprising the transdermal delivery composite, and a method for preparing the transdermal delivery composite.
1 . A composite for transdermal delivery comprising a cyclodextrin-based metal-organic framework (CD-MOF), a polymer, and an active ingredient,
wherein the cyclodextrin-based metal-organic framework is prepared from cyclodextrin and potassium hydroxide (KOH); and
wherein the polymer is selected from the group consisting of pullulan, polylactic acid, pullulan-poly-(L)-lactic acid, a triblock copolymer of polyethylene glycol (PEG)-polycaprolactone (PCL)-polyethylene glycol (PEG) and mixtures thereof.
2 . The composite for transdermal delivery according to claim 1 , wherein the cyclodextrin is alpha-cyclodextrin, beta-cyclodextrin or gamma-cyclodextrin.
3 . The composite for transdermal delivery according to claim 2 , wherein the cyclodextrin is gamma-cyclodextrin.
4 . The composite for transdermal delivery according to claim 1 , wherein the polymer is selected from the group consisting of pullulan-poly-(L)-lactic acid, a triblock copolymer of polyethylene glycol (PEG)-polycaprolactone (PCL)-polyethylene glycol (PEG) and mixtures thereof.
5 . The composite for transdermal delivery according to claim 1 , wherein 0.01 to 100 parts by weight of the polymer are included based on 10 parts by weight of the cyclodextrin-based metal-organic framework.
6 . The composite for transdermal delivery according to claim 1 , wherein the active ingredient is one or more selected from the group consisting of a moisturizer, a whitening agent, an anti-wrinkle agent, a UV blocking agent, a hair growth promoter, vitamin or a derivative thereof, amino acid or peptide, an anti-inflammatory agent, an acne therapeutic agent, a microbicide, female hormone, a keratolytic agent, a natural product, oil, wax, butter, paraffin, a higher fatty acid, an ester and a silicone.
7 . A cosmetic composition comprising the composite for transdermal delivery according to claim 1 .
8 . The cosmetic composition according to claim 7 , comprising 1 to 60% by weight of the composite for transdermal delivery.
9 . A method for preparing a composite for transdermal delivery comprising:
i) dissolving cyclodextrin, potassium hydroxide (KOH), a polymer, and an active ingredient in a solvent,
ii) forming crystals in the crystallization solvent from the solution obtained in step (i) using a gas diffusion crystallizer and
iii) washing the crystals formed in step (ii) and drying the crystals,
wherein the polymer is selected from the group consisting of pullulan, polylactic acid, pullulan-poly-(L)-lactic acid, a triblock copolymer of polyethylene glycol (PEG)-polycaprolactone (PCL)-polyethylene glycol (PEG) and mixtures thereof.
10 . The method for preparing a composite for transdermal delivery according to claim 9 , wherein the cyclodextrin is alpha-cyclodextrin, beta-cyclodextrin or gamma-cyclodextrin.
11 . The method for preparing a composite for transdermal delivery according to claim 10 , wherein the cyclodextrin is gamma-cyclodextrin.
12 . The method for preparing a composite for transdermal delivery according to claim 9 , wherein the polymer is selected from the group consisting of pullulan-poly-(L)-lactic acid, a triblock copolymer of polyethylene glycol (PEG)-polycaprolactone (PCL)-polyethylene glycol (PEG) and mixtures thereof.
13 . The method for preparing a composite for transdermal delivery according to claim 9 , wherein the solvent of step (i) is selected from the group consisting of water, propylene glycol and mixtures thereof.
14 . The method for preparing a composite for transdermal delivery according to claim 9 , wherein 10 to 200 parts by weight of cyclodextrin, 1 to 100 parts by weight of potassium base and 0.01 to 50 parts by weight of the polymer are dissolved based on 100 parts by weight of the solvent in step (i).
15 . The method for preparing a composite for transdermal delivery according to claim 9 , wherein the crystallization solvent in step (ii) is selected from the group consisting of methanol, ethanol and mixtures thereof.
16 . The method for preparing a composite for transdermal delivery according to claim 9 , wherein the active ingredient is one or more selected from the group consisting of a moisturizer, a whitening agent, an anti-wrinkle agent, a UV blocking agent, a hair growth promoter, vitamin or a derivative thereof, amino acid or peptide, an anti-inflammatory agent, an acne therapeutic agent, a microbicide, female hormone, a keratolytic agent, a natural product, oil, wax, butter, paraffin, a higher fatty acid, an ester and a silicone.